AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to
AmerisourceBergen is updating its outlook for fiscal year 2021. The Company does not provide forward-looking guidance on a GAAP basis, as discussed below in Fiscal Year 2021 Expectations. Adjusted diluted EPS guidance has been raised from the previous expectation of
"AmerisourceBergen continues to prove our vital role as a key pillar in the healthcare system. Our solid performance in the March quarter was fueled by our associates who continue to work diligently to provide innovative solutions for our partners to ultimately serve their patients," said Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen.
"Driven by our purpose of being united in our responsibility to create healthier futures, we are strengthening our portfolio of solutions for customers, expanding on our leadership in specialty, focusing on execution and leveraging our capabilities and expertise to support pharmaceutical innovation," Mr. Collis continued. "AmerisourceBergen is well-positioned to deliver long-term, sustainable growth, supported by our diverse and inclusive teams and our investments in our people and culture."
Second Quarter Fiscal Year 2021 Summary Results
|
GAAP |
|
Adjusted (Non-GAAP) |
|
Revenue |
|
|
|
|
Gross Profit |
|
|
|
|
Operating Expenses |
|
|
|
|
|
|
|
||
Interest Expense, Net |
|
|
|
|
Effective Tax Rate |
|
|
|
|
Net Income Attributable to ABC |
|
|
|
|
Diluted Earnings Per Share |
|
|
|
|
Diluted Shares Outstanding 
AMERISOURCEBERGEN CORP
NYSE:ABCABC RankingsABC Latest NewsABC Stock Data
215.85M
|